Colgate-Palmolive (NYSE:CL) Position Raised by Ingalls & Snyder LLC

Ingalls & Snyder LLC lifted its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 1.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 23,557 shares of the company’s stock after acquiring an additional 282 shares during the period. Ingalls & Snyder LLC’s holdings in Colgate-Palmolive were worth $2,142,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of CL. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive in the 4th quarter worth about $32,000. Hager Investment Management Services LLC acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $36,000. Reston Wealth Management LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth approximately $42,000. Synergy Asset Management LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $49,000. Finally, Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive during the 3rd quarter worth $53,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $87.87 on Friday. The company has a market capitalization of $71.79 billion, a price-to-earnings ratio of 24.96, a P/E/G ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a 1-year low of $82.83 and a 1-year high of $109.30. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. The stock’s fifty day simple moving average is $89.83 and its 200-day simple moving average is $96.54.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the business posted $0.87 EPS. On average, sell-side analysts predict that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CL. TD Cowen decreased their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $101.16.

Get Our Latest Report on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.